AptarGroup ATR
$140.08 −$0.26 (-0.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $140.08 0.00%
Open$142.35
Prev close$140.34
Day range$139.85 – $143.88
Volume868.1K
Market cap$8.88B
P/E (TTM)33.8
Dividend yield1.37%
ATR Stock News
Headlines matching AptarGroup or the ATR ticker, most recent first.
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $155 Positive
- BofA Securities Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $172
- BofA Securities Maintains AptarGroup(ATR.US) With Buy Rating
- Analysts' Opinions Are Mixed on These Healthcare Stocks: AptarGroup (ATR) and Contineum Therapeutics, Inc. Class A (CTNM)
- William Blair Maintains AptarGroup(ATR.US) With Hold Rating
- Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $160 Negative
- BofA Securities Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $173 Positive
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $145
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $145 Positive
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- BofA Securities Maintains AptarGroup(ATR.US) With Hold Rating, Cuts Target Price to $145 Negative
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
- Wells Fargo Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $144 Positive
No comments yet — be the first to weigh in on ATR.
Sign in to join the discussion.